UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that adult patients ...
The market is undergoing a fundamental maturation from niche chemical curiosity to essential industrial pillar, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback